175 results on '"Izbicka, E"'
Search Results
2. A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense™, G3139) and irinotecan in patients with metastatic colorectal cancer
3. Elimination of extrachromosomal c-myc genes by hydroxyurea induces apoptosis
4. Effects of Human Tumor Cell Lines on Local New Bone Formation In Vivo
5. Mitogenic Lectin Concanavalin A Induces Calvarial Bone Formation In Vivo via Indomethacin-Sensitive Pathway
6. Phase II study of oblimersen sodium (G3139) and docetaxel in patients with metastatic hormone-refractory prostate cancer
7. A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors
8. Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units
9. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells
10. 620 A Study of PNT2258 (DNA-targeted Blocker of BCL2 Expression) in Patients with Advanced Solid Tumors
11. PP 9 Men and women display different proteomic diagnostic profiles in non small cell lung cancer
12. 1424 POSTER Methods of Identification and Diagnosis of Lung Cancer Using Classification Systems
13. 79P MASS SPECTROMETRIC IDENTIFICATION OF NOVEL PROTEOMIC BIOMARKERS OF NON-SMALL CELL LUNG CANCER
14. 80P MULTIPLEX IMMUNOASSAY ASSAY ANALYSIS OF DIFFERENTIALLY EXPRESSED BIOMARKERS OF NON-SMALL CELL LUNG CANCER
15. A phase I, pharmacokinetic and pharmacodynamic study of sorafenib (S), a multi-targeted kinase inhibitor in combination with temsirolimus (T), an mTOR inhibitor in patients with advanced solid malignancies
16. 327 POSTER Improved method for preparation of formalin-fixed paraffin-embedded tissue for mass spectrometric analysis
17. 328 POSTER Rapid, efficient and reproducible SELDI chip robotic preparation method
18. Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts
19. A phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of the farnesyl transferase inhibitor (FTI) R115777 in combination with weekly paclitaxel in patients (pts) with advanced solid cancers
20. Efficient induction of apoptosis by ONYX-015 adenovirus in human colon cancer cell lines regardless of p53 status
21. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay
22. Systemic Administration of Acidic Fibroblast Growth Factor (FGF‐1) Prevents Bone Loss and Increases New Bone Formation in Ovariectomized Rats
23. In vitro antitumor activity of the novel marine agent, Ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients
24. Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming units
25. Preclinical and clinical strategies for development of telomerase and telomere inhibitors
26. The effects of cytokines and growth factors on osteoblastic cells
27. Pp60 c‐src expression and activity in MG‐63 osteoblastic cells modulated by PTH but Not required for PTH‐mediated adenylate cyclase response
28. Hormonal regulation of pp60c-src expression during osteoclast formation in vitro.
29. Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.
30. Rat retina has an active and stable ubiquitin-protein conjugating system
31. The synthesis and screening of 1,4,5,8-naphthalenetetracarboxylic diimide-peptide conjugates with antibacterial activity
32. G-quadruplexes as targets for drug design
33. Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line
34. Mitogenic Lectin Concanavalin A Induces Calvarial Bone Formation In Vivovia Indomethacin-Sensitive Pathway
35. Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos
36. Design and synthesis of fluoroquinophenoxazines that interact with human telomeric g-quadruplexes and their biological effects
37. Activity of TER286 against human tumor colony-forming units
38. ChemInform Abstract: HYDROLYSIS ENTHALPY CHANGES FOR SELECTED FIVE- AND SIX-MEMBERED CYCLIC ESTERS
39. Hydrolysis enthalpy changes for selected five- and six-membered cyclic esters
40. Cancer drug development yesterday, today and tomorrow.
41. Mitigation of Insulin Resistance by Natural Products from a New Class of Molecules, Membrane-Active Immunomodulators.
42. Membrane Active Immunomodulator As a Novel Therapy for an Infectious Bacterial Disease, Buruli Ulcer.
43. Diethyl Azelate for the Treatment of Brown Recluse Spider Bite, a Neglected Orphan Indication.
44. Adaptive Membrane Fluidity Modulation: A Feedback Regulated Homeostatic System and Target for Pharmacological Intervention.
45. Adaptive Membrane Fluidity Modulation: A Feedback Regulated Homeostatic System Hiding in Plain Sight.
46. Oral Azelaic Acid Ester Decreases Markers of Insulin Resistance in Overweight Human Male Subjects.
47. Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide.
48. Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women.
49. Effects of alpha-difluoromethylornithine on markers of proliferation, invasion, and apoptosis in breast cancer.
50. Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.